Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Juno Therapeutics
Juno Therapeutics
[video]Big Biotech Is Bustling With Buyouts
Motley Fool
Mon, 01/29/18 - 09:21 am
biotech
M&A
Celgene
Juno Therapeutics
Sanofi
Bioverativ
5 Things Celgene's Management Just Said That You'll Want to Know
Motley Fool
Sat, 01/27/18 - 09:39 am
Celgene
M&A
Juno Therapeutics
Impact Biomedicines
Otezla
drug pricing
Celgene's task: Turn its shiny new toys into growth drivers
Biopharma Dive
Thu, 01/25/18 - 05:51 pm
Celgene
M&A
Juno Therapeutics
Impact Biomedicines
Biotech M&A In 2018: A Tsunami Or A Ripple?
Forbes
Tue, 01/23/18 - 09:22 am
biotech
M&A
Sanofi
Bioverativ
Celgene
Juno Therapeutics
Bluebird Bio Shouldn’t Be Blue About Celgene’s Juno Deal
Washington Post, DC
Tue, 01/23/18 - 08:43 am
Bluebird Bio
Celgene
Juno Therapeutics
M&A
CAR-T
Celgene Buys Juno Therapeutics: A Risky $9B Bet
Forbes
Mon, 01/22/18 - 05:39 pm
Celgene
Juno Therapeutics
M&A
Is Juno worth a $10B-$12B buyout price? Analysts see megabucks deal in the making on reported Celgene talks
Endpoints
Wed, 01/17/18 - 10:09 pm
Juno Therapeutics
Celgene
M&A
Celgene is reportedly in talks to buy Juno Therapeutics
CNBC
Wed, 01/17/18 - 11:40 am
Celgene
Juno Therapeutics
M&A
CAR-T
Juno inks CAR-T supply deal with Thermo Fisher
BioPharma Dive
Thu, 12/21/17 - 10:29 pm
Juno Therapeutics
Thermo Fisher
CAR-T
[video]ASH 2017 Recap: These Were the Big Winners and Losers
Motley Fool
Sat, 12/16/17 - 08:39 am
ASH2017
Bluebird Bio
Juno Therapeutics
Spark Therapeutics
Biomarin
JNJ
Celgene
ASH 2017: What you missed
BioPharma Dive
Wed, 12/13/17 - 06:35 pm
ASH17
Biomarin
Spark Therapeutics
Gilead Sciences
Novartis
Juno Therapeutics
AbbVie
Roche
JNJ
ASH 2017: CAR-T Wallops Blood Cancer
Motley Fool
Tue, 12/12/17 - 11:16 am
ASH2017
CAR-T
gene therapy
Novartis
Kymriah
Yescarta
Gilead Sciences
Juno Therapeutics
JCAR017
Juno inks deals with Eli Lilly as it looks to leapfrog leaders on BCMA
Endpoints
Thu, 12/7/17 - 08:56 am
Juno Therapeutics
Eli Lilly
LY3039478
Multiple Myeloma
3 Top Biotech Stocks for 2018
Motley Fool
Mon, 11/13/17 - 09:23 am
Celgene
Juno Therapeutics
JCAR017
Cara Therapeutics
CR845
Juno uses lethal neurotox lessons to guide Goldilocks formula for its next-gen CAR-T
Endpoints
Mon, 11/13/17 - 09:18 am
Juno Therapeutics
CAR-T
JCAR017
Juno analysis of shuttered study offers clues for CAR-T
BioPharma Dive
Fri, 11/10/17 - 10:30 pm
Juno Therapeutics
CAR-T
JCAR015
clinical trials
9 Notable Biotechs Presenting At This Year's ASH Meeting
Yahoo
Tue, 11/7/17 - 09:56 am
ASH
Bluebird Bio
LentiGlobin
Ziopharm Oncology
Bellicum
BPX-501
Spark Therapeutics
SPK-8011
Biomarin
BMN 270
Juno Therapeutics
CAR-T
Novartis
Geron
imetelstat
Immunogen
IMGN632
IMGN779
3 Biotech Stocks That Soared This Week
Motley Fool
Sat, 11/4/17 - 05:37 pm
Juno Therapeutics
Adamas
Stemline
JCAR017
Gocovri
SL-401
Juno Therapeutics' 3rd Quarter Boosted by Potential Rival Novartis
Yahoo/Motley Fool
Thu, 11/2/17 - 09:26 am
Juno Therapeutics
earnings
Novartis
#ASH17: The big loser in CAR-T, Juno is making a bid to seize the fast lane to frontrunner status
Endpoints
Wed, 11/1/17 - 06:52 pm
ASH
CAR-T
Juno Therapeutics
JCAR017
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
next ›
last »